Author

Peng Zhao

University of GeorgiaORCID 0000-0002-9296-5293Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Peng Zhao6 papers · University of California, Los Angeles

Biology Disciplines

Click to filter author papers

Immunology· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

Lance WellsiD· 3 shared Agnes A. Walsh· 1 shared Alexandra DrakakiiD· 1 shared Amelia EscolanoiD· 1 shared Amrita BasuiD· 1 shared Beatrice H. HahniD· 1 shared Bin Hu· 1 shared Caroline Boroughs· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Lance WellsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis

Neil G. Patel, Alexandra Drakaki, Farhan Valummel, Jack C. Moore, Amrita Basu, Bin Hu, Xiaolin Dong, Peng Zhao, Mees Botman, Emily Spector, Mark Cameron Mochel, Lance Wells, Jennifer E. Koblinski, Marten A. Hoeksema, Ryan J. Weiss

This study identifies an EZH2/TRIM28 epigenetic axis that regulates heparan sulfate remodeling and promotes melanoma metastasis.

Communications Biology · Sep 19, 2026Peer-reviewedMolecular Biology

Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles

Seo-Ho Oh, Dedeepya R. Gudipati, Wei Shi, Peng Zhao, Winston Wu, Jeffrey C. Boyington, Hardik K. Nariya, Emily G. McGhee, Tala Azzam, Vedhika Raghunathan, Chumeng Yang, Catherine F. Yang, Christian R. Lee, J Kim, Tongqing Zhou, , Rui Kong

This paper develops glycan-engineered alphavirus-like particles as HIV-1 fusion peptide immunogens, showing improved antibody responses and neutralization against multi-clade HIV-1.

npj Vaccines · Nov 14, 2025Peer-reviewedImmunology

Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates.

Ignacio Relaño-Rodríguez, Jianqiu Du, Zi Jie Lin, Margaret Kerwin, Marta Tarquis-Medina, Eduardo Urbano, Jiayan Cui, Meagan Watkins, Peng Zhao, Rumi Habib, Sukanya Ghosh, Joyce H. Park, Caroline Boroughs, Agnes A. Walsh, Mariane B. Melo, , Amelia Escolano

This paper introduces WIN332, an engineered immunogen that elicits N332-glycan-independent V3-glycan antibodies in nonhuman primates after a single immunization.

bioRxiv · Sep 4, 2025 · PreprintImmunology